Exo00 0020 01
Exondys 51 Injection
Product Images NDC 60923-363
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Exondys 51 (NDC 60923-363). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sarepta Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Exo00 0020 02
EEXONDYS 51 is a medication that is administered through injection and its main active ingredient is eteplirsen. Further information about the purpose, usage or dosage is not available from the given text.*
Exo00 0020 03
This is information related to the Exondys 51 medication. It is an injection for intravenous infusion used for the treatment of a specific medical condition. The medication is available in single-dose vials that need to be refrigerated and must be protected from light. It is recommended to use a 0.2-micron in-line filter during infusion. The text also includes the manufacturer's contact details and a specific NDC code.*
Exo00 0020 04
EXONDYS 51 is an injection medication with the active ingredient eteplirsen. The amount of eteplirsen in the injection is 3, 15 or 9 milliliters per milligram. Further details are provided with a label number of 0013635.*
Exo00 0020 05
This is a medication called Exondys 51 that is injected intravenously. It comes in a single-dose vial and contains 500mg of eteplirsen, which is to be diluted before use. It is recommended to use a 0.2 micron in-line filter during infusion. The medication should be stored in the refrigerator between 2°C-8°C and should not be frozen or exposed to light. The medication is manufactured by Sarepta Therapeutics and contains sodium chloride, potassium chloride, potassium phosphate monobasic, and sodium phosphate dibasic, anhydrous. The pH of the medication may be adjusted using sodium hydroxide and hydrochloric acid. It does not contain preservatives. Dosage and administration information are available in the prescribing information.*
Exo00 0020 06
Exondys 51 is a medication that is provided via a single dose injection of 500 mg/10 mL (50 mg/mL) for intravenous infusion after dilution. The medication should be refrigerated at 2°C-8°C (36°F-46°F). It is prescribed by Sarepta Therapeutics, Inc. and the National Drug Code (NDC) is 60923-284-1. The provided RN number is 92013637.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
